2018-01-30 19:42:57 UTC

Reprocessing of Duodenoscopes: How Do We Get to Zero?

Jan. 31, 2018

Prevention of endoscope transmitted infection will be the focus of a session at the 2018 AGA Tech Summit, a meeting for stakeholders in GI innovation.

Innovation goes beyond the development of new products — it is also the process of revolutionizing current technologies. A technology ripe for innovation is the duodenoscope, an indispensable medical tool that has been implicated as responsible for spreading multidrug-resistant bacterial infections, likely due to its complex design and cleaning processes.

At the 2018 AGA Tech Summit, the AGA Center for GI Innovation and Technology will bring together device companies, physicians and government agencies for a session investigating the current challenges with duodenoscopes and discuss possible long-term solutions to decrease and eliminate device transmitted infections. This session will guide industry as they continue to innovate on endoscope design to ensure we reach our goal of zero device-associated infections.

The 2018 AGA Tech Summit will take place March 21-23 in Boston, Massachusetts. If you have ideas for improving scope design or other new technologies or devices that can improve the GI space, join us for our annual meeting of GI innovation stakeholders.

A message for GIs who perform ERCP: the AGA Center for GI Innovation and Technology recommends all gastroenterologists follow the guidance from CDC and FDA, which reflect changes to device design and updated reprocessing recommendations.

More on ERCP

Attend the AGA Postgraduate Course for Practical, Take Home Information

Feb. 12, 2018

Join us on June 2-3 in Washington, D.C. This course is held in conjunction with Digestive Disease Week® (DDW) 2018.

Voluntary Recall of Pentax ED-3490TK Duodenoscopes

Feb. 8, 2018

Recall designed to reduce the potential for leakage of patient fluids into the closed elevator channel and under the distal cap.

Compendium of AGA 2017 Clinical Guidance

Dec. 21, 2017

Are you up-to-date on AGA's latest clinical guidance?